- Home
- CRVO vs GEOS Comparison
CRVO vs GEOS Comparison
Compare CRVO & GEOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- GEOS
- Stock Information
- Founded
- CRVO 2001
- GEOS 1980
- Country
- CRVO United States
- GEOS United States
- Employees
- CRVO N/A
- GEOS N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- GEOS Industrial Machinery/Components
- Sector
- CRVO Health Care
- GEOS Industrials
- Exchange
- CRVO Nasdaq
- GEOS Nasdaq
- Market Cap
- CRVO 67.4M
- GEOS 72.9M
- IPO Year
- CRVO N/A
- GEOS 1997
- Fundamental
- Price
- CRVO $7.79
- GEOS $18.40
- Analyst Decision
- CRVO Strong Buy
- GEOS
- Analyst Count
- CRVO 6
- GEOS 0
- Target Price
- CRVO $19.17
- GEOS N/A
- AVG Volume (30 Days)
- CRVO 109.2K
- GEOS 173.3K
- Earning Date
- CRVO 11-11-2025
- GEOS 08-07-2025
- Dividend Yield
- CRVO N/A
- GEOS N/A
- EPS Growth
- CRVO N/A
- GEOS N/A
- EPS
- CRVO N/A
- GEOS N/A
- Revenue
- CRVO $7,776,968.00
- GEOS $115,527,000.00
- Revenue This Year
- CRVO N/A
- GEOS N/A
- Revenue Next Year
- CRVO N/A
- GEOS N/A
- P/E Ratio
- CRVO N/A
- GEOS N/A
- Revenue Growth
- CRVO N/A
- GEOS N/A
- 52 Week Low
- CRVO $1.80
- GEOS $5.51
- 52 Week High
- CRVO $19.50
- GEOS $21.60
- Technical
- Relative Strength Index (RSI)
- CRVO 33.57
- GEOS 56.83
- Support Level
- CRVO $9.61
- GEOS $16.10
- Resistance Level
- CRVO $10.48
- GEOS $17.29
- Average True Range (ATR)
- CRVO 0.64
- GEOS 1.22
- MACD
- CRVO -0.29
- GEOS -0.20
- Stochastic Oscillator
- CRVO 0.96
- GEOS 50.58
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About GEOS Geospace Technologies Corporation (Texas)
Geospace Technologies Corp is engaged in designing and manufacturing seismic instruments and non-seismic equipment used in the oil and gas industry. The company has three different segments: oil and gas markets, adjacent markets, and emerging markets. The oil and gas markets segment, which accounts for the majority of the company's revenue, includes traditional exploration products, wireless exploration products, and reservoir characterization products and services. The adjacent markets business is closely tied to the oil and gas markets and includes imaging products and industrial products. The company operates globally across Asia, Canada, Europe, the United States, South America, Mexico, and other regions with a majority of its revenue being generated within the United States.